Eximia Research Enhances Clinical Trial Access with Strategic Expansion
Eximia Research Network Expands into New Territory
Eximia Research, a growing integrated clinical trial network, has taken a vital step forward by acquiring Integrated Clinical Trial Services, Inc. (ICTS). This acquisition signifies a landmark expansion aimed at increasing access to pioneering clinical trials and healthcare solutions throughout the nation. Eximia Research is committed to revolutionizing patient care through innovative research and dedicated service.
About Integrated Clinical Trial Services
ICTS, located in a prominent area of West Des Moines, Iowa, holds the title of the only full-time dedicated research clinic within the greater vicinity. Established in 2005 by Joe and Kristine Majors, this clinic has developed a stellar reputation for delivering quality clinical trials in various therapeutic fields. These include pediatrics, neurology, pain management, dermatology, and metabolic disorders. ICTS has played a critical role in educating the public and local healthcare providers about the importance and benefits of clinical trials.
Leadership and Expertise at ICTS
With a wealth of experience spanning over 19 years, ICTS is led by Kristine Majors, a registered nurse with a Master of Science in her field and extensive expertise in academia and clinical trials. She gained recognition as the first RN to earn an associate professorship at Des Moines University College of Osteopathic Medicine. Kristine has been involved in significant research endeavors, with findings published in widely respected medical journals. Partnering with her husband Joe, who brings his business savvy, they have successfully grown ICTS into a multidisciplinary facility crucial for new treatment developments.
The Vision of Eximia Research
Upon joining the Eximia Research Network, Kristine Majors expressed her enthusiasm: "We are eager to utilize the support and resources provided by Eximia to enhance our focus on patient care and clinical research advancement. We are excited about the prospects for growth and the opportunity to serve our community better with the help of this innovative organization." This partnership is anticipated to significantly improve patient access to cutting-edge clinical trials and breakthrough treatments.
Integration for Enhanced Patient Care
The inclusion of ICTS into Eximia's network is set to enhance the medical landscape in West Des Moines. Patients will gain improved access to innovative clinical trials and expert healthcare services. This collaboration not only seeks to elevate patient outcomes but also strives to make strides in advancing medical science.
Eximia's Commitment to the Midwest
The addition of ICTS completes Eximia's strategic presence in the Midwest, complementing existing sites such as Sundance Clinical Research based in St. Louis. This broadened footprint allows Eximia to better serve communities across the Midwest, Southeast, Mid-Atlantic, and Western regions of the United States.
About Eximia Research
Eximia Research champions a network of high-performing and dedicated clinical research sites that prioritize excellence in clinical trials spanning a wide array of therapeutic areas. With a clear focus on quality data, patient safety, and operational efficiency, Eximia collaborates with premier healthcare providers to facilitate the introduction of innovative treatments to communities nationwide. Their mission is to bolster medical research and enhance healthcare outcomes, all from their headquarters.
Frequently Asked Questions
What does the acquisition of ICTS mean for Eximia Research?
The acquisition expands Eximia Research's network, improving access to clinical trials and pioneering healthcare solutions for patients in new regions.
How long has ICTS been operating?
Integrated Clinical Trial Services has been providing dedicated clinical research services since 2005, gathering over 19 years of experience.
What specialties does ICTS focus on?
ICTS specializes in various therapeutic areas, including pediatrics, general medicine, neurology, dermatology, and metabolic disorders.
Who leads the clinical trials at ICTS?
Kristine Majors, co-founder and a registered nurse, leads the clinical oversight at ICTS, supported by her husband Joe Majors.
What is Eximia Research's goal moving forward?
Eximia Research aims to enhance patient outcomes and advance medical science by expanding its network and services nationwide.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.